Jade Biosciences (JBIO) Prepaid Assets (2020 - 2026)
Jade Biosciences posted quarterly Prepaid Assets of $7.2 million for Q1 2026, up 2171.07% year-on-year from $318000.0 in Q1 2025, and down 42.95% on a QoQ basis from $12.7 million in Q4 2025.
Jade Biosciences (JBIO) has 7 years of Prepaid Assets data on file, last reported at $7.2 million in Q1 2026.
- For the quarter ending Q1 2026, Prepaid Assets rose 2171.07% year-over-year to $7.2 million; the trailing twelve-month figure through Mar 2026 stood at $7.2 million (up 2171.07% YoY), and the FY2025 full-year result was $12.7 million, up 4623.13% from the prior year.
- Prepaid Assets for Q1 2026 stood at $7.2 million, down from $12.7 million in the prior quarter.
- Across five years, Prepaid Assets topped out at $12.7 million in Q4 2025 and bottomed at $268000.0 in Q4 2024.
- The 5-year median for Prepaid Assets is $2.0 million (2025), against an average of $3.0 million.
- Peak annual rise in Prepaid Assets reached 4623.13% in 2025, while the deepest fall reached 83.6% in 2025.
- A 5-year view of Prepaid Assets shows it stood at $478000.0 in 2022, then decreased by 21.55% to $375000.0 in 2023, then retreated by 28.53% to $268000.0 in 2024, then soared by 4623.13% to $12.7 million in 2025, then sank by 42.95% to $7.2 million in 2026.
- The last three Prepaid Assets figures came in at $7.2 million (Q1 2026), $12.7 million (Q4 2025), and $2.5 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Jade Biosciences | 1.06 Bn | 1.06 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 7.22 Mn |
| Dec 31, 2025 | 12.66 Mn |
| Sep 30, 2025 | 2.46 Mn |
| Jun 30, 2025 | 2.04 Mn |
| Mar 31, 2025 | 318,000.00 |
| Dec 31, 2024 | 268,000.00 |
| Sep 30, 2024 | 1.88 Mn |
| Jun 30, 2024 | 6.56 Mn |
| Mar 31, 2024 | 1.94 Mn |
| Dec 31, 2023 | 375,000.00 |
| Sep 30, 2023 | 2.40 Mn |
| Jun 30, 2023 | 2.37 Mn |
| Mar 31, 2023 | 1.11 Mn |
| Dec 31, 2022 | 478,000.00 |
| Sep 30, 2022 | 2.58 Mn |
| Jun 30, 2022 | 1.46 Mn |
| Mar 31, 2022 | 4.81 Mn |
| Dec 31, 2021 | 240,000.00 |
| Sep 30, 2021 | 2.22 Mn |
| Jun 30, 2021 | 159,000.00 |
| Dec 31, 2020 | 23,000.00 |